PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 139 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,455,697 | -34.3% | 87,272 | +8.8% | 0.00% | 0.0% |
| Q2 2023 | $2,215,124 | +77.7% | 80,200 | +48.0% | 0.00% | 0.0% |
| Q1 2023 | $1,246,600 | +110.8% | 54,200 | 0.0% | 0.00% | – |
| Q4 2022 | $591,322 | +75.5% | 54,200 | +35.5% | 0.00% | – |
| Q3 2022 | $337,000 | -7.4% | 40,000 | -13.0% | 0.00% | – |
| Q2 2022 | $364,000 | -87.8% | 46,000 | -63.6% | 0.00% | -100.0% |
| Q1 2022 | $2,995,000 | +90.8% | 126,463 | +175.5% | 0.00% | 0.0% |
| Q4 2021 | $1,570,000 | +93.1% | 45,900 | 0.0% | 0.00% | – |
| Q3 2021 | $813,000 | -60.5% | 45,900 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $2,060,000 | +159.8% | 45,900 | +50.0% | 0.00% | – |
| Q1 2021 | $793,000 | +40.6% | 30,600 | +9.3% | 0.00% | – |
| Q4 2020 | $564,000 | +3.1% | 28,000 | 0.0% | 0.00% | – |
| Q3 2020 | $547,000 | +10.7% | 28,000 | 0.0% | 0.00% | – |
| Q2 2020 | $494,000 | +333.3% | 28,000 | +73.9% | 0.00% | – |
| Q1 2020 | $114,000 | +28.1% | 16,100 | +27.8% | 0.00% | – |
| Q4 2019 | $89,000 | -41.1% | 12,600 | 0.0% | 0.00% | – |
| Q3 2019 | $151,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |